Cargando…
Management of Advanced Prostate Cancer in the Precision Oncology Era
SIMPLE SUMMARY: This review article details new precision oncology-based therapeutics used to treat advanced prostate cancer. Metastatic castration-resistant prostate cancer remains an incurable diagnosis, however newly identified biomarkers have expanded treatment repertories for some patients with...
Autores principales: | Gillette, Claire M., Yette, Gabriel A., Cramer, Scott D., Graham, Laura S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177563/ https://www.ncbi.nlm.nih.gov/pubmed/37174018 http://dx.doi.org/10.3390/cancers15092552 |
Ejemplares similares
-
Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
por: Jillson, Lauren K., et al.
Publicado: (2021) -
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology
por: Jadvar, Hossein
Publicado: (2018) -
Targeting cancer metabolism in the era of precision oncology
por: Stine, Zachary E., et al.
Publicado: (2021) -
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018) -
Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine
por: Dulaney, Caleb R., et al.
Publicado: (2016)